BioCryst Pharmaceuticals | BCRX - Capitalização De Mercado





Capitalização De Mercado Alterar Data
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Chugai Pharma JPY 11.23T 985.7B 2026-11
Daiichi Sankyo JPY 5.22T 356.74B 2026-09
DBV Technologies USD 739M 491M 2026-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Glaxosmithkline GBP 101.7B 4.58B 2026-11
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Neurocrine Biosciences USD 14.46B 45M 2026-11
Novavax USD 1.09B 316M 2025-12
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.65B 276M 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11